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Abstract
Antigenic drift allowing escape from neutralizing antibodies is an important feature of transmission and survival of influenza
viruses in host populations. Antigenic drift has been studied in particular detail for influenza A H3N2 and well defined
antigenic clusters of this virus documented. We examine how host immunogenetics contributes to determination of the
antibody spectrum, and hence the immune pressure bringing about antigenic drift. Using uTOPE
TM bioinformatics analysis
of predicted MHC binding, based on amino acid physical property principal components, we examined the binding affinity
of all 9-mer and 15-mer peptides within the hemagglutinin 1 (HA1) of 447 H3N2 virus isolates to 35 MHC-I and 14 MHC-II
alleles. We provide a comprehensive map of predicted MHC-I and MHC-II binding affinity for a broad array of HLA alleles for
the H3N2 influenza HA1 protein. Each HLA allele exhibited a characteristic predicted binding pattern. Cluster analysis for
each HLA allele shows that patterns based on predicted MHC binding mirror those described based on antibody binding. A
single amino acid mutation or position displacement can result in a marked difference in MHC binding and hence potential
T-helper function. We assessed the impact of individual amino acid changes in HA1 sequences between 10 virus isolates
from 1968–2002, representative of antigenic clusters, to understand the changes in MHC binding over time. Gain and loss of
predicted high affinity MHC-II binding sites with cluster transitions were documented. Predicted high affinity MHC-II binding
sites were adjacent to antibody binding sites. We conclude that host MHC diversity may have a major determinant role in
the antigenic drift of influenza A H3N2.
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Introduction
Influenza viruses cause a major burden of disease, and spread
rapidly throughout global populations. Many factors contribute to
the infectivity and transmissibility of influenza viruses. Among these
are the presence of specific sialic acid receptors [1], the enzyme
cleavage sites in hemagglutinin [2], peptide transporter processing
[3], innate immune defenses [4], and the presence of neutralizing
antibody [5]. The high degree of variability of the hemagglutinin
protein subunit (HA1), to which neutralizing antibody binds, is well
known. Antigenic drift allowing escape from neutralizing antibodies
is an important feature of the continued transmission and survival of
seasonal influenza viruses in populations from year to year [6,7].
This makes the task of selecting vaccines an ongoing challenge [8].
Antigenic drift is attributed to selection under pressure of an
immune response and has been measured primarily by escape
from the neutralizing effect of antibodies [7]. Antigenic drift has
been studied in particular detail for influenza A H3N2, which
emerged first in epidemic form in 1968. Multiple specific amino
acid changes in the HA1 protein associated with antigenic drift
have been identified [9–14]. Smith et al [9] have mapped the effect
of progressive genetic mutations leading to antigenic change, as
detected by hemagglutination inhibition with polyclonal ferret
antisera. This study showed well-defined antigenic clusters of
influenza A H3N2 virus isolates emerging chronologically.
Antibody alone can neutralize influenza virus infectivity and
prevent infection [15,16]. In primary infection the antibody
response is the result of both B-cell and T–cell stimulation and is
polyclonal. The spectrum of antibodies present in a polyclonal
response is a function of which B-cells and T-helper cells are
stimulated. The neutralizing antibody response on re-exposure is
the combination of neutralization by residual circulating antibody,
anamnestic stimulation of a subset of both B-memory cells and T-
memory cells, as well as de novo antibody formation. Unlike the
molecular mechanism of neutralization of virus by antibody, the
pathways of antibody production which involve function of T-cells
are dependent on MHC binding of peptides and hence vary with
host MHC allelic diversity. CD8+ cytotoxic T-cells (CTL) have
been shown to have a role in limiting the duration of virus
shedding and in eliminating virus infected cells [17,18].
CD4+ cells are not effective at achieving viral clearance in the
absence of B-cells; a T-dependent antibody response is a key
component of the CD4+ role [16,19]. CD4+ T-cell responses are
also essential for a fully developed CD8+ T-cell response to
influenza [20].
Screening studies using synthetic peptide probes have identified
CD4+ T-cell epitopes broadly distributed in the HA and
neuraminidase [21,22]. Importantly, Barnett et al in 1989 [23]
showed the common location of CD4+ epitopes and B-cell
epitopes, primarily in the variable regions of HA1 in H3N2
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polymorphism in antigenic drift. CD8+ CTL epitopes have been
identified in most influenza A proteins [24]. Single amino acid
sequence differences in H3N2 nucleoprotein peptides binding to
MHC-I molecules have been shown experimentally to allow
escape from recognition by cytotoxic lymphocytes [25–28].
In understanding the role of antigen presenting cells (APC) in
influenza, considerable emphasis has been placed on MHC-I
CD8+ epitopes [29–31]. The role of B-cells as APC in influenza
has received less attention. While all APC within the lung were
able to stimulate MHC-I restricted responses, B-cells were very
inefficient compared to macrophages or dendritic cells in this role
[30]. The inability to infect B-cells with influenza, attributed to the
absence of NF-kB signaling [32], means they may not be exposed
to influenza core proteins and so may have a different APC
function for influenza than do dendritic cells and macrophages.
Given the role of T-helper cells in determining the antibody
spectrum, and CTLs in curtailing virus shedding, understanding
the influence of host immunogenetics is a key part of understand-
ing the immunological pressure bringing about antigenic drift.
Experimental studies of T-cell epitopes necessarily take a
reductionist approach, in which individual interactions of single
MHC alleles and specific virus peptides are examined.
In this study we use a bioinformatics approach to examine the
interface of influenza virus diversity with host immunogenetics at a
population level and to address the consequent variations in
immunologic selection pressure.
We recently described a method, termed uTope
TM analysis, for
whole proteome mapping of predicted binding to MHC-I and
MHC-II molecules. In this approach binding affinity is represent-
ed by the three dominant physical property principal components
of each amino acid making up each peptide 9-mer or 15-mer,
respectively [33,34]. This method offers significant advantages
over previous bioinformatics approaches, which depend on
position specific matrices [35]. In the present study, we applied
uTOPE
TM analysis to ask how patterns of antigenic drift in
influenza H3N2, as monitored by antibody binding over time,
compared to the patterns of predicted T-cell epitopes reflected in
predicted MHC binding within the HA1 of influenza H3N2. We
examined the interaction of protein sequences for the HA1 of 447
H3N2 virus isolates with 35 MHC-I HLAs and 14 MHC-II alleles.
We compared clusters based on predicted MHC binding patterns
with those described by Smith et al [9]. We further examined the
impact of individual changes in HA1 amino acid sequences
between virus isolates representative of different antigenic clusters
over time to understand the changes in MHC binding. By
analyzing all possible MHC-peptide interactions within HA1 of
several hundred virus isolates and for a large number of MHC
alleles, sufficient data density is achieved to allow patterns of MHC
binding to be appreciated and analyzed. We examined how host
immunogenetics contributes to determination of the antibody
spectrum and hence the immune pressure bringing about
antigenic drift. We conclude that MHC diversity likely has a
major determinant role in the antigenic drift of influenza A H3N2.
Methods
Database and Statistical Software
All mathematical operations, database operations, and statistical
analysis were carried out with JMPH version 9.0 or JMP
GenomicsH version 5/SAS 9.2 using the JMPH scripting language
[36]. The MegAlignH application within LaserGeneH v8 was used
for sequence alignments. Much of the work involved populations
of numerical data standardized to zero mean and unit variance.
The term s is used throughout to describe the numerical data in
standard deviation units.
Workflow
Figure 1 outlines the sequence of analytical steps applied. In
particular it differentiates between those analyses conducted on all
influenza proteins (validation), all H3N2 HA1 proteins (cluster
analysis), and on a representative subset of H3N2 HA1 (detailed
analysis on the impact of mutations).
Viruses and Curation of Sequences
A set of approximately 156,000 influenza A proteins was
assembled from the Genbank Influenza database in December
2010. HA1 proteins for all H3N2 isolates from 1968 to present
Figure 1. Workflow of bioinformatics analysis.
doi:10.1371/journal.pone.0026711.g001
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were not in the primary influenza database; these were located by
Genbank searches and consolidated with the primary collection.
Several quality control procedures were applied to the dataset
prior to use. A small number of duplicate sequences with the same
Virus ID but different Genbank accession numbers were removed.
All amino acid position assignments used in this paper are based
on the N-terminal methionine and include the signal peptide. As
the clustering algorithms used are intolerant of missing amino
acids, sequences in the database without a signal peptide were
edited to add a consensus signal peptide. Sequence submitters
have not used uniform C-termini for HA1; we terminated all HA1
at position 345 prior to cluster analysis. One sequence, A/
Moscow/10/1999(H3N2)_49339009, had several amino acid
deletions marked and was removed.
The resulting virus dataset comprised 260 HA1 used by Smith et
al [9] which we designated by a prefix of the Smith cluster
designation (HK68, EN72 etc.). An additional 187 H3N2 HA1
proteins from isolates dated 1968–2002 were included and given
the prefix of the year of the isolate and ‘‘NON’’ (NON1998,
NON2001 etc.).
For each Smith cluster a single representative virus isolate was
selected for further analysis. The isolates selected are shown in
Table 1. These were chosen from those which, on initial clustering
analysis based on MHC binding patterns, were located in the
mainstream of the Smith cluster groups. As our list only comprised
two isolates from TX77 and in many instances these isolates




TM methods used to predict MHC binding affinity
using a neural network prediction scheme based on amino acid
physical property principal components have been described in
detail elsewhere [33,34]. Briefly, for MHC-II the protein was
broken down into 15-mer peptides each offset by 1 amino acid. The
peptide 15-mers were converted into vectors of principal compo-
nents wherein each amino acid in a 15-mer is replaced by three z-
scale descriptors. {z1(aa1),z2(aa1),z3(aa1)}, {z1(aa2),z2(aa2),z3(aa2)},
…{ z 1(aa15),z2(aa15),z3(aa15} that are effectively physical property
proxy variables. With these descriptors, ensembles of neural
network prediction equation sets were developed using publicly
available datasets of peptide-MHC binding data wherein the
inhibitory concentration 50% (ic50) has been catalogued as a
measure of binding affinity of the peptides for a number of different
HLAs [37,38]. Because the ic50 data have a numerical range in
excess of 10,000-fold, they were natural logarithm transformed to
give the data better distributional properties for predictions, and
subsequent statistical analysis used the log normal inhibitory
concentration50 (ln(ic50)). For each of the 15-mers predicted ln(ic50)
values werecomputed for fourteen different human MHC-II alleles:
DRB1*01:01, DRB1*03:01, DRB1*04:01, DRB1*04:04,
DRB1*04:05, DRB1*07:01, DRB1*08:02, DRB1*09:01,
DRB1*11:01, DRB1*13:02, DRB1*15:01, DRB3*01:01,
DRB4*01:01, DRB5*01:01. The peptide data was indexed to the
N-terminal amino acid; thus each prediction corresponds to the 15-
amino acid peptide downstream from the index position.
An identical process was then followed with all 9-mer peptides
for prediction of binding to 35 MHC-I alleles: A*01:01, A*02:01,
A*02:02, A*02:03, A*02:06, A*03:01, A*11:01, A*23:01, A*24:02,
A*24:03, A*26:01, A*29:02, A*30:01, A*30:02, A*31:01, A*33:01,
A*68:01, A*68:02, A*69:01, B*07:02, B*08:01, B*15:01, B*18:01,
B*27:05, B*35:01, B*40:01, B*40:02, B*44:02, B*44:03, B*45:01,
B*51:01, B*53:01, B*54:01, B*57:01, B*58:01.
Each of the alleles has a different characteristic mean and
standard deviation of bindingaffinity to 9-mer and 15-mer peptides.
Thus for statistical comparisons involving multiple HLA alleles, the
predicted ln(ic50) values were standardized to zero mean and unit
standard deviation on a within-protein basis. For the virus HA1
sequences the standardization of the affinity of the HLA binding
predictions was done on a within-virus basis. For the validation test
set, the grand mean and grand standard deviation of each HLA
across all 10 influenza proteins from multiple influenza viruses
represented in the dataset (124 different proteins in all), wereused to
compute the standardized binding affinity of the isolated peptides.
Validation Dataset and Approach
To evaluate the validity of the epitope prediction method in the
context of influenza virus, a dataset of T-cell epitopes experimen-
tally defined by others in each of the proteins of influenza A viruses
was prepared from records at the Immune Epitope Database
(IEDB, iedb.org) and by reference to the source publications. From
the available experimental data, a set of 460 non-redundant
experimentally defined unique peptides was assembled. This
included 296 experimentally determined epitope positive and
164 negative. Epitopes had been defined since 2000 using
chromium release, ELISPOT, or MHC tetramer binding and
the HLA restriction was known. Details of the selection process are
included in Table S1, which includes a table of the epitopes used.
Using a set of 156,000 influenza A proteins, representing all
influenza proteins, we generated a master array of the predicted
binding affinity to HLA alleles for all 9-mer and 15-mer peptides
for each protein. Those corresponding to the experimentally
determined epitopes were compared. For this purpose the
recursive partitioning platform of JMP using a 5 K-fold cross-
validation was used. The area under the receiver operator
characteristic curve (AROC) was used as a measure of the
sensitivity and accuracy of the predictions. A confusion matrix was
generated showing agreement/ disagreement (true positives, false
positives, true negatives, false negatives) with the 460 experimental
measurements. We have previously described the use of
uTOPE
TM analysis for B-cell epitope prediction [34]. This
approach was applied to the cluster representative isolates.
MHC binding predictions and analysis and clustering
methods
All subsequent analyses were derived from a subset of the
master array of individual MHC-peptide binding affinities of all
Table 1. Influenza H3N2 virus isolates selected as cluster
representatives.
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then for a representative subset of 10 HA1 proteins.
Cluster analysis was conducted to examine patterns of similarity
and dissimilarity in MHC binding between virus isolates. For
clustering of the virus protein sequences, the amino acid sequence
of each isolate protein was represented by vectors of predicted
ln(ic50) data sequentially indexed by 1 amino acid as described
above. Two forms of data were used depending on the application.
For certain analyses the ln(ic50) data were standardized by
subtraction of the mean and division by the standard deviation
to produce a uniform scale with a mean of zero and standard
deviation of one, a process common in statistical analysis. In other
analyses non-standardized ln(ic50) data were used. Clustering was
done using the hierarchical and K-means clustering platforms of
JMPH. These platforms have a wide range of tools to assess the
quality of the analysis, and these were used as appropriate. The K-
means platform was used initially to obtain an estimate of the
optimal number of clusters within the dataset for each of the HLA
alleles [39]. Using the 447 viruses in the data set with each of 35
MHC-I and 14 MHC-II alleles, the optimal number of clusters
ranged from 17 to 23. As a compromise, the larger of these
numbers was used for all subsequent work with hierarchical
clustering where the number of clusters of interest can be manually
specified for graphical and textual output. To order the clusters in
the hierarchical clustering process, principal component analysis
was first carried out on the dataset, and the order of the clusters
was based on the first principal component of the dataset under
consideration. Clusters of HA for the 447 viruses based on MHC
binding were assembled; initially one by one for each HLA to
compare to the Smith clusters. We then prepared hierarchical
arrays which compared binding for each HLA to the HA1 of
selected representatives of each cluster.
Permuted population binding patterns
For certain analyses and graphical representations of MHC
binding by the population, the permuted minimum algorithm
described previously was used [34]. This is based on the concept
that within a heterozygous or homozygous individual, the HLA
allele providing the highest binding affinity to any specific peptide
will prevail at each MHC locus. All possible heterozygous and
homozygous HLA pair combinations at each allele were
determined and the best affinity of the two selected. These values
were then averaged across all possible combinatorial pairs of alleles
available in the prediction data set to arrive at a prediction for
each peptide for a metapopulation. Hence, for N=14 MHC-II,
105 combinations are used (((N
22N)/2)+N). The MHC binding
affinity to a peptide can change over several orders of magnitude
for a single amino acid index position increment along the protein.
As an MHC can bind in any of several different indexing positions,
if one of the indexing positions of either of the heterozygous alleles
provides for a high binding affinity then the peptide will effectively
be trapped in that location. Thus, to compute the permuted
phenotype, the highest binding affinity for each allelic pair within
a narrow averaging window (62–64 amino acids) around the
index amino acid position was recorded and then averaged over all
potential combinatorial pairs in a population. For plotting the
results we applied the minimal distortion polynomial filter of
Savitsky and Golay [40].
Changes in binding affinity
We developed algorithms and statistical metrics that enabled
quantifying and visualizing changes in individual peptide-MHC
binding arising from the amino acid changes between each pair of
cluster-representative viruses stepwise in chronological order
(HK68 to EN72…HK68 to FU02). Changes in predicted binding
of a peptide, indexed to the N-terminus amino acid of the 9-mer or
15-mer, were scored on a 5-point basis as shown in Table 2. The
sign and magnitude of the scoring parameter indicate the direction
and size of the change in ln(ic50) value; hence a negative sign
indicates a shift toward higher affinity. A 22 therefore indicates a
large change in affinity with the result being a high affinity binder.
This allowed us to analyze (1) how many amino acid mutations
were needed to bring about a significant change in MHC binding,
(2) to determine the aggregate of changes in the HA1 protein over
time, and (3) to plot where within HA1 mutations leading to gain
or loss of high affinity MHC binding were occurring.
Results
Validation of analysis
A meta-analysis was carried out using experimentally defined
epitopes from all influenza proteins compared to the MHC
affinities predicted by the in silico approach. Results are shown in
Figure 2 for T-cell epitopes. There are caveats to interpretation of
Table 2. Classification of changes in predicted peptide HLA binding affinity due to amino acid changes.
Classification High affinity binder status Binding affinity before and after
Description of amino acid change
impact
22 New .21s to #21s Large increase in affinity (.1s change) to
surpass threshold and become a new high
binder
21 Retained #21s to #21s Already a high binder, further affinity
increase
0 No Change #21s to #21s High affinity, no change
+1 Retained #21s to #21s A high binder, affinity loss but remains above
threshold as a high binder
+2L o s t #21s to .=0 High affinity initially; large decrease to below
high binder threshold
The impact on binding affinity associated with amino acid changes arising in cluster transition was determined. Based on impact of the mutations on predicted binding
affinity a classification code was assigned to each peptide for each of the affected MHC molecules. The threshold of 21s was selected based on the outcome of
recursive partitioning (Figure S1). The peptides were then assigned to different one of five different classifications according to whether high affinity binding was
gained, lost or retained above the threshold. Only high binders were considered, so some peptides that did not surpass the threshold were not included in the analysis
of the particular transition.
doi:10.1371/journal.pone.0026711.t002
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several experimental techniques, each with different endpoints and
carried out by numerous laboratories without inter-laboratory
validation. An extensive international collaboration effort for
assessment of T-cell epitopes in Type I diabetes [41] has shown
cross-laboratory standardization to be critical to producing valid
T-cell epitope results. Nevertheless, by pooling epitopes charac-
terized over several years by many laboratories, we obtained a
much broader comparison than would have been possible within
our own laboratory. Experimentalists tend to focus on testing and
reporting on epitope peptides that are positive. This characteristic
has three consequences that potentially affect the statistical
analysis: the overall mean of the dataset is less than the mean of
the proteins from which the epitopes were selected, the number of
positives documented experimentally is much larger than the
negatives, and the same epitope is tested experimentally numerous
times by different laboratories. With these points in mind, we
carried out a comparison between our in silico predictions and the
assay results combining all HLAs, peptides, and experimental
methods into a single consolidated dataset after having eliminated
redundant measurements on the same epitope. Figure S1, provides
the same analysis with redundant measurements included. For the
combined, non-redundant dataset, the AROC across all experi-
mental methods (Cr release, ELISPOT, and MHC tetramers) was
0.89 with an optimal cutpoint of 20.53s (below the overall mean)
on a standardized binding scale for selection of a positive. Thus, a
binding affinity of less than 20.53s can be interpreted as being a
prediction metric for a positive T-cell response. This does not
mean that binding predictions .20.53s might not be associated
with a positive cellular response, but they cannot be reliably
predicted as such by our neural net method. At this cutpoint, our
predictions for the 460 experimentally characterized epitope were
in agreement for 382 (83%) of the epitopes. For the remaining
17%, we cannot be sure whether our prediction or the
experimental determination was the correct one; we note that in
some cases experimental determination by two different methods
also gave conflicting outcomes. Between the cutpoint and the
overall mean of the dataset there is considerable overlap between
the predictions for the positive and negative group. Both negative
and positive categories span both sides of the mean with the
negatives averaging about +0.4 s and the positives average about
21.4 s. As the binding data was normally distributed, we chose to
use a somewhat more conservative cut point of 21s of
standardized binding data in the remainder of the study. In a
recent study by Greenbaum et al [38] the 20
th percentile was
chosen as a cutpoint for inclusion of data for a clustering analysis
of MHC-II binding to a dataset of peptides, quite close to the 21s
value used here. A more detailed discussion and an analysis
showing the effects of epitope selection bias and measurement
redundancy is provided in Figure S1. The comparison of B-cell
epitope predictions and curated epitope characterizations, less
central to this study, are shown in Figure S2.
Observations of binding patterns in the master array
As an illustration of the binding prediction array output,
Figure 3 shows binding affinity for two HLAs, DRB1*04:01 and
A*02:01, for a small subset of sequential peptides from two virus
isolates (HK68 A/Bilthoven/16190/68 and EN72 A/England/
42/1972), as well as the difference in binding affinity between the
isolates at each position. The binding affinity varies greatly with a
single amino acid displacement along the protein. As shown in
Figure 3 for the HK68 isolate, a DRB1*04:01 MHC-II binding a
Figure 2. Relationship between MHC binding prediction and curated epitope characterizations. Panel A. The area under the ROC curve
of 0.88 reflects the categorization reliability at the optimum cut-point of 20.53s chosen by the recursive categorization process. Panel B. The chart
shows that the mean of the positive class was approximately 21.5s (center of the diamond). The mean of the negative class is approximately +0.4s.
The ends of the boxes are the 25th and 75th percentile and the horizontal line in the box is the median. The ends of the lines are the 5th and 95th
percentiles of the respective distributions. Many points are plotted on top of each other but the histograms on the right shows the data distribution.
A cut-point of 20.53s was chosen by the recursive categorization process (dotted line). The cutpoint at 21s (solid line) is a more rigorous threshold
which was used as a readily understandable criterion throughout the study. Panel C. The confusion matrix documents agreement and disagreement
between predictive and experimental methods.
doi:10.1371/journal.pone.0026711.g002
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very different outcome from one which binds one or two amino
acids downstream (ln(ic50)=21.16 s and 23.16 s). Likewise,
single amino acid substitutions can result in a significant change in
predicted MHC binding affinity (see right hand side of each panel
in Figure 3). In assessing the effect of an amino acid mutation on
MHC binding to its impact on antibody binding, it is important to
recognize the multiple registers of MHC binding that may be
affected by a single amino acid. Although conceptualized and
treated as specific 15-mers with a core 9-mer binding domain, the
large entropy contribution implies a more dynamic association of
the HLA with the peptide [41], where the peptide might adopt
several energetically equivalent binding registers. Further, the
effect of an amino acid change is not necessarily, or only, when it
occurs at the index position of a peptide, but rather may extend
upstream to all 15-mer or 9-mer registers in which it participates.
For example, substitution of glycine by aspartate at position 160
between the HK68 isolate and the EN72 isolate brings about
changes of .1s in binding affinity in multiple registers upstream
for both the alleles shown.
Cluster analysis of H3N2 HA1 based on predicted MHC
binding patterns over time
The array of predicted binding affinities of 345 successive
peptides for each of the 447 HA1 was clustered, based on the
patterns of binding affinity for each one of the 35 MHC-I and 14
MHC-II alleles. These are very large arrays comprising over
154,000 datapoints. Dendrograms were drawn of the clustering
patterns for each MHC allele. Two representative dendrograms
are shown in Figures S3 and S4, these are for the widely studied
HLAs A*02:01 and DRB1*04:01. These large figures can be
zoomed to allow the list of viruses to be reviewed. Observation of
the dendrograms shows that MHC-I binding patterns were more
conserved than MHC-II binding patterns. Low binding affinity
regions of the protein remained unchanged, in some cases through
34 years. Based on the K-means clustering algorithm the 447
viruses were grouped into 23 clusters. Although in the present
analysis there are more clusters than were found by Smith et al [9],
this difference is largely due to additional metrics used in the
present study. Despite the larger number, clustering based on
MHC binding closely mirrors that identified by Smith et al based
on antibody hemagglutination inhibition studies and shows clearly
defined clusters following a chronological progression.
To facilitate comparisons between HLA alleles of the clustering
patterns seen in the large dendrograms, cell plots of contingency
tables were assembled. For each HLA allele these plots count the
number of isolates in each cluster. Representative examples are
shown in Figure 4. Isolates from each Smith cluster group are
present in 1–4 contiguous clusters based on MHC binding. A few
exceptions are noted. For example, inthe case of A*02:01, the Smith
BE92 cluster, which comprises 57 virus isolates, spans 7 clusters.
Three WU95 isolates (A/Madrid/G252/93(H3N2))_49339273, A/
Netherlands/399/93(H3N2))_49339305, and A/Netherlands/372/
93(H3N2))_49339297 ) cluster with BE92; notably these are isolates
which Smith found to be interdigitated with BE92.
Each HLA allele generates a slightly different contingency plot
indicative of different clustering patterns. However, the plot
patterns fall into three related groups within each of MHC-I A,
MHC-I B and DRB1, examples of which are in Figure 4. For each
HLA, isolates comprising each Smith cluster tend to locate
together, but in a different relative order. NON isolates (the
contemporaneous virus set not studied by Smith et al) are arrayed
below the Smith cluster isolates in each cell plot and form an
approximately parallel pattern by date order for each HLA.
Figure 3. Impact of single amino acid changes on MHC-I and MHC-II binding. The examples of MHC-I A*02:01 and DRB1*04:01 binding to
peptides in a section of HA1 from two isolates representing clusters HK68 and EN72 (isolates as shown in Table 1) show (a) that a single amino acid
displacement can significantly impact predicted binding affinity and (b) that a single amino acid change impacts predicted MHC binding across
multiple registers. For both A*02:01 and DRB1*04:01 the predicted binding affinity of the peptide starting at index position 160 is significantly
different from that in either of the two positions starting at 161 or 162. A change in the amino acid at position 160 may contribute to the appearance
of a new MHC-1 A*02:01 high affinity binding site with index position 152; it may also contribute to new high affinity MHC-II DRB1*04:01 binding
peptides with index positions at 160, 157, 154, and 149 and the loss of a high affinity binding peptide with index at position 147. Standardized
binding affinity is shown as standard deviations below the mean (s). Position numbering is from the signal peptide N terminus.
doi:10.1371/journal.pone.0026711.g003
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In light of the observation that each HLA generated a different
cluster pattern, we selected a single representative virus from each
of ten Smith clusters and examined their interaction with the
different MHC alleles more closely. These viruses are listed in
Table 1.
Hierarchical clustering shows diverse binding by HLA
The peptide binding affinity arrays for all peptides in the 10
representative HA1 were clustered based on similarity of the
binding affinity patterns for each HLA. Within-virus standardiza-
tion of each HLA allele prediction was done using the Johnson Sb
distribution, which is most appropriate for measurements with
experimental data having upper and lower bounds [42]. The
output for one virus (HK68 A/Bilthoven/16190/68) is shown in
Figure 5. Arrays for the other nine viruses are in Figure S5. In
these plots the peptide binding patterns for all HLAs can be
compared.
In general, more variation in binding affinity pattern is seen
between MHC-II alleles than between MHC-I alleles. It should be
Figure 4. Representative cell plot patterns of the clustering of virus isolates based on predicted MHC binding patterns of HA1
compared to clusters defined by antibody binding. Hierarchical clustering of affinity patterns in HA1 of 447 virus isolates was carried out for
each HLA as shown in Figure S3 and S4 using the Ward method. Each cluster was assigned a numerical ID from 1 to 23, shown in the X-axis. Cross-
tabulations were then prepared that tallied the cluster numerical ID with the clusters identified by Smith et al [9] and shown in the upper half of the
y-axis. The lower half of each plot shows the clustering of contemporaneous virus isolates that were not evaluated by Smith et al. arrayed against the
year of isolation in the y-axis. The color scale shows the count of viruses in each cell. Each HLA generated a similar pattern but with different counts.
Three broad types of pattern were noted and representative examples are shown here for MHC-I A and B and MHC-II DRB.
doi:10.1371/journal.pone.0026711.g004
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coloration indicating affinity of binding the N-terminus of a 9-
mer or 15-mer. When the arrays for each of the virus isolates are
compared, the patterns across the protein are clearly visible but
they differ, sometimes greatly, between HLA alleles at any single
peptide. Marked differences in binding affinity can arise from a
single amino acid displacement (see Figure 3). In these plots it is
also apparent that certain regions of the molecule, for example
peptides initiating at amino acids 155–190 and 220–250, have a
much higher frequency of predicted high affinity binders (purple-
blue coloration). Other regions, for example amino acids 40–60,
have a preponderance of low affinity predictions (yellow–red).
When the ranking of HLA based on predicted MHC binding
pattern is compared between each of the ten representative
viruses, differences in rank order were noted. Figure 6 shows the
variation in mean and standard deviation of predictions between
HLA alleles. While some alleles were consistently high affinity
binders (A*30:02, B*57:01, DRB1*01:01) and some were
consistently low affinity binders (A*23:01, B*53:01,
DRB3*01:01), others ranked differently for each virus. Again
more variation in rank order and affinity was noted for MHC-II
alleles than MHC-I.
Permuted population binding patterns
The cluster analyses have considered each HLA allele in
isolation. However, in a population of individual hosts it is further
necessary to consider the way in which a heterozygote carrying
different combinations of alleles might respond. As described
previously [34], we have found that a relatively simple combina-
torial calculation for a heterozygous population captures some of
the qualitative patterns noted above by the clustering graphics. For
each of the ten representative viruses, graphical representations of
the MHC binding affinity for the permuted population are shown
in Figure 7. The regions with high and low binding for many
alleles, noted in the cluster graphics above clearly stand out in
these plots. The population plots bring together data for multiple
immunological characteristics (predicted MHC-I binding as the
red line, predicted MHC-II binding as the blue line, B-cell epitope
probability by orange lines) for a metapopulation. They identify
sequences which contain the highest probability, based on HLA
genotype-pairs, of MHC-I and MHC-II high binding affinity (10
th
percentile of minimum trace shown in red and blue ribbons,
respectively) and high probability B-cell binding (orange ribbons
show 25
th percentile Bayesian probability). We have shown that
this type of plot correlates closely with experimentally defined
epitopes in a very wide range of proteins [34]. Notably there is
overlap of many MHC-I and MHC-II high probability binding
sequences, and likewise overlap or proximity of MHC binding
regions to B-cell binding. Each of the lines in these graphs are the
running affinity averages of a very large number of combinatorial
binding data (105 HLA pairs for MHC-II and 630 pairs for MHC-
I). The range and pattern of changes of each of these averages is
very characteristic for each protein. When the ten viruses are
compared in Figure 7, subtle differences are seen in the trace of the
average MHC-I and MHC-II binding (red line and blue line,
respectively) over time. The plots clearly show minima (high
affinity MHC binding) in areas that have been identified as being
highly mutable and close to antibody binding sites [6,9,14] and
that are visible as qualitative patterns in the cluster graphics
(Figure 5). The orange shading marks predicted B-cell epitope
Figure 5. Hierarchical Cluster of predicted MHC-I and MHC-II binding to HA1 from a HK68 cluster representative isolate. Hierarchical
clustering of predicted binding of multiple MHC-I and MHC-II alleles to consecutive peptides in HA1 of Influenza A/Bilthoven/16190/68 was done by
the method of Ward using Johnson Sb distribution standardized binding data [42]. The Y-axis lists the MHC alleles. The X-axis shows the protein
amino acid positions N-C. Each pixel represents the 9-mer or 15-mer peptide which starts at that amino acid position. The binding data for each HLA
was first submitted to principal component analysis and the first principal component was used as an ordering variable. In each case clusters are
indicated by the color of the y-axis legend. Comparable plots of binding to HA1 of other cluster representative viruses are shown in Figure S5. The
color scale shows the binding affinity as ln(ic50). Purple-blue colors indicate strong binders and red-orange pixels are weak binders.
doi:10.1371/journal.pone.0026711.g005
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mapped by Wiley at al [6]. Once adjusted for the 16 amino acid
signal peptide, Wiley’s Site A is at 138–162, Site B 171–213, Site C
66, 69–70, Site D 217–238, and Site E 276 and 278.
Gain and loss of high affinity binding sites between
cluster representatives
Based on the apparent coincidence between the areas of high
affinity binding predictions and high mutability, the temporal
changes in MHC binding over the entire HA1 molecule were
examined by comparing the transitions between representative
viruses.
Amino acid mutations affecting MHC binding
Figure 8 shows that predicted MHC-II binding affinity changes
and consequently epitope gain or loss occurred when 1 to 8
amino acid changes happened within a 15-mer peptide, however
most changes resulted from 1, 2 or 3 amino acids mutations. For
the MHC-II predictions it appears that the highest probability for
generating a new high affinity binder is either 2 or 3 simultaneous
mutations, whereas a single amino acid change can have
dramatic effects on MHC-I binding. A striking feature is that
simultaneous changes in several amino acids within either a 9-
mer or 15-mer can give rise to effectively quantum changes in
binding affinity. Thus a small number of simultaneous amino acid
mutations triggering a change in MHC-II binding affinity could
give rise to a change in the spectrum of epitopes presented to T-
helper cells. An example of the data set showing the changes is
provided in Table S2.
Cumulative change in MHC binding
We noted that there were regions of the HA1 molecule within
which relatively high (21s) binding of peptides was retained over
the entire period from 1968–2002. Other regions of the molecule
showed very rapid changes in HLA binding characteristics. We
therefore developed a system that enabled the visualization of
temporal changes in binding behavior for all HLAs over the entire
HA1 sequence over time. Figure 9 shows the aggregate change in
MHC binding peptides for all peptides in HA1 at each cluster
transition, as represented by the subset of ten viruses for all MHC-
I and MHC-II alleles (Figure 9a and 9b). Figure 9c shows the
aggregate changes for DRB1*04:01 as one example of the change
in a single allele. Figure S6 provides the corresponding plots for
other DRB alleles, each of which differs in the rate of change.
Using the cluster transition of HK68 to EN72 as an example,
during the ,4 year period the majority of the HLA binding
peptides were unchanged, but a few new high binders appeared
and a few were lost. Comparing the changes across 34 years from
HK68 to FU02 there is an accumulation of new high affinity
binders. Even after this time a few high affinity peptides (,21s)
are still retained, but most have been replaced. The patterns are
similar for each of the successive transitional pairings. While the
overall pattern is obvious, there are some HLAs in which
practically all of the high affinity binders are lost over the 34
year period. On an individual allele basis very few high affinity
MHC binding sites are retained intact through all the cluster
transitions. It should be noted that the signal peptide (16 aa) was
excluded from these plots as it was conserved (and in some cases
inserted for alignment).
Position of changes in MHC binding within HA1
As Figure 9 considers the entire HA1 molecule, it is also of
interest to know where in the sequence the change (or
conservation) is occurring. Therefore we next constructed a
graphic to show the locations within the HA1 proteins of peptides
where binding affinity changes occurred between representative
virus isolates. Figure 10 shows the cumulative gain in predicted
high binding peptides across the nine cluster transitions for each of
14 MHC-II alleles. Figure 11 shows conversely the predicted high
binding affinity lost by each allele over the same transitions.
Figure 12 maps the high MHC binding affinity sites retained. Most
addition and loss of high affinity MHC binding is seen in those
peptides with index positions between amino acids 150–180 and
245–290. This places the highest probability of MHC-II binding
change adjacent to or overlapping with neutralizing B-cell epitopes
[6]. It is interesting that, in many cases, amino acids identified by
Smith as essential to cluster transitional changes (and marked as
red lateral lines in these figures) would be members of these 15-
mer peptide. Once again we note the differences between
individual MHC-II alleles. Figures 10a and 10b only represent
the highest affinity binding peptide losses and gains (categories 22
and +2 in Table 2). Losses and gains of binding sites with less
change in affinity (categories 21 and +1 in Table 2) are provided
in Figures S7a and S7b but follow broadly similar patterns.
Discussion
Our analysis provides the first comprehensive map of predicted
MHC-I and MHC-II binding affinity for a broad array of HLA
Figure 6. Comparison of mean and variation of binding affinity between HLA. Hierarchical clustering was performed as shown in Figure 3
for all cluster representative viruses shown in Table 1. A. shows the grand mean and standard deviation of predicted MHC-I binding affinity over all
peptides in HA1 for the 10 representative viruses by allele. B. shows the same data for MHC-II.
doi:10.1371/journal.pone.0026711.g006
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for all 9-mer and 15-mer candidate MHC-I and MHC-II binding
peptides in the HA1 protein of 447 H3N2 influenza virus isolates
representing a span of 34 years, during which the changing pattern
of antibody reactivity is known. This approach allows us to
examine how a large group of viruses exhibiting antigenic drift
may interact with an immunogenetically diverse host population.
The correlation of the experimental T-cell epitope definitions in
the validation set with our predicted MHC binding affinity
indicates that the in silico approach we have adopted is a valid
Figure 7. Permuted population plots showing predicted MHC-I and MHC-II binding and B-cell epitope sequences in the HA1 of ten
selected viruses. The MHC-I (red line) and MHC-II (blue line) binding data are the permuted average binding for all combinations of alleles of each
used in this study. Amino acid principal component neural net prediction of B-cell epitope sequences (orange vertical lines) are based on a neural net
trained by BepiPred 1.0 output (not permuted). The horizontal red and blue bands are respectively the top 10th percentile of the permuted MHC- I
and MHC-II predicted binding affinity. The orange bands are the top 25th percentile of B-cell epitope sequence predictions. In each case the line or
band marks the index N terminal position of the 9-mer or 15-mer peptide for which it provides the data.
doi:10.1371/journal.pone.0026711.g007
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TM
prediction provides a means of large scale analysis of potential host
interface with hundreds of virus isolates. This allows a higher level
view than can be derived from experimental data, which
necessarily address a limited set of circumstances of virus isolate
and HLA. In silico prediction provides a rapid and cost effective
screening tool and guide to planning experimental design. As a
single amino acid displacement can fundamentally change binding
affinity of a peptide, it is essential to examine every candidate 9-
mer or 15-mer peptide to appreciate the distribution of MHC
binding sites across a protein. Many experimental efforts to
determine T-cell epitopes have been undercut by the economics of
peptide synthesis, which have dictated use of insufficient peptides
to examine all possible sequential peptides. Our predictions
suggest this pragmatic approach has likely caused many potential
epitopes to be missed. The arrays used for the visualization and
analysis shown here correspond to over 7 million individual
peptide-MHC interactions, beyond the scope of the laboratory
bench. When viewed on this large scale, pattern recognition is
possible across the whole protein as well as between HLA alleles.
We have shown that the clustering of H3N2 viruses based on
predicted MHC binding patterns within HA1 follows closely that
described by Smith et al from analysis of antibody binding patterns
[9]. Predicted MHC binding at any given peptide differs between
HLA alleles. Single amino acid mutations or displacements can
provoke dramatic differences in MHC binding. Similarly,
Figure 8. Number of amino acid mutations associated with the appearance or loss of high affinity binding peptides. The number of
amino acid substitution events in 9-mer and 15-mer peptides from HA1 of the 447 viruses which result in appearance or loss of predicted high affinity
binding of MHC-I and MHC-II respectively. Criteria for loss or gain are shown in Table 2. MHC-I loss: blue; MHC-I gain: tan; MHC-II loss: red; MHC-II gain:
green.
doi:10.1371/journal.pone.0026711.g008
Figure 9. Predicted high affinity MHC binding peptides gained, lost and conserved in HA1 in transitions between temporal clusters
of H3N2. For cluster representative viruses shown in Table 1, the scoring system shown in Table 2 was used to assign a categorical classification to
predicted high affinity peptides according to whether they were new (22), showed enhanced binding of an existing high binder (21), conserved (0),
showed reduced binding but were still high affinity (+1), or lost their status as predicted high affinity binders (+2). The plots show the aggregate
number of each class of change in the HA1 protein associated with the transitions between clusters (HK68 to EN72, HK68-FU02 etc). Panel A shows
the aggregate for all MHC-I alleles studied; Panel B shows the aggregate for all MHC-II alleles shown; Panel C shows DRB1*04:01 as an example of a
single allele, other MHC-II alleles are shown in Figure S6.
doi:10.1371/journal.pone.0026711.g009
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mer can give rise to the appearance or loss of potential T-cell
epitopes. We observed most variability in predicted MHC binding
in positions adjacent to neutralizing antibody binding sites.
Several steps occur between the uptake of influenza virus or
protein by an APC and the presentation of peptides by MHC
molecules as potential T-cell epitopes. Variables such as antigen
dose, peptide:MHC affinity, and the cytokine environment can all
have an effect on the process [43–45]. Nevertheless, MHC binding
is an absolute prerequisite and the stability of the peptide MHC
complex plays an important role in determining T-cell clonal
selection [43]. Hence, predictions based on affinity of MHC-
peptide binding are a good starting point in T-cell epitope
identification, whether evaluated in silico or by tetramer binding.
Proteasomal cleavage likely has a uniform and relatively random
effect on all proteins. While each protein will have its own
characteristic unfolding during the degradation process, peptides
with higher affinity binding to MHC simply have a greater
competitive advantage for MHC capture and presentation.
Prediction tools (NetChop at CBS, cbs.dtu.dk/services/NetChop/)
c a nb eu s e dt og a i na na s s e s s m e n to ft h ei m p a c t so fp r o t e a s o m a l
processingonthepresentationofpeptidesto bindtoanMHC-I.The
proteolytic activity of both the immunoproteasome and constitutive
proteasome is quite aggressive. Indeed, several trials using
recommended settings for the NetChop predictors show high
probability of cleavage every 3–5 amino acids. There are no reliable
predictors of MHC-II peptide production in APC.
T-cell responses have been reported to many epitopes in
hemagglutinin in natural and experimental infections [21,24,27,46].
HA peptide epitopes which elicit CD4+ T-cell responses have been
showntoprovide partialprotection whenused tovaccinatemice [47].
T-cell epitopes were shown to be located in the antigen binding sites
of HA and shown to be affected by amino acid changes that occur
during antigenic drift [23]. The most recent comprehensive study of
CD4+ T-cell epitopes in hemagglutinin of H1N1 viruses by Richards
etal [22], using naive DR1 transgenic mice and overlapping peptides,
demonstrated that CD4+ T-cell epitopes are far more widely
distributed in HA1 than previously appreciated.
Figure 10. Position of peptides in which high affinity MHC-II binding is gained in cluster transition. The categorical classification of
peptides according to whether they gained or lost high affinity binder status (Table 2) as a result of the transition between two cluster representative
viruses (Table 1) was plotted across all HA1 amino acid positions for 14 MHC-II’s. Each panel of nine lanes shows the changes in binding for the cluster
transition indicated at the top of the panel (HK68-EN72 etc). Each of the lanes within the panel is the change in predicted binding affinity for a
different MHC-II allele, left to right DRB1*01:01, DRB1*03:01, DRB1*04:01, DRB1*04:04, DRB1*04:05, DRB1*07:01, DRB1*08:02, DRB1*09:01,
DRB1*11:01, DRB1*13:02, DRB1*15:01, DRB3*01:01, DRB4*01:01, DRB5*01:01. The red lines on each side are amino acid positions identified by Smith
et al [9] as key mutation points for antigenic drift, these are taken from Smith’s Table I and corrected for the presence of signal peptides in our
numbering convention. This Figure shows the positions of predicted new high affinity binding peptides gained in the cluster transition. The color
scale shown in the scale at left is the count of amino acid changes at a given position for all HLAs which result in the category of change mapped.
Figure S7 shows intermediate changes in high affinity binding (21 and +1 categories).
doi:10.1371/journal.pone.0026711.g010
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change is, on one hand, not surprising; both are derivates of
nucleotide sequences and mutation therein. As shown in
Figures 10,11,12, many of the key amino acid positions important
to antibody-detected cluster transitions can also affect MHC binding
affinity of 15-mer peptides in multiple registers. On the other hand,
the close relationship between antibody-detected antigenic drift and
change in predicted MHC binding suggests a more functional
relationship. T-cell responses to high affinity binding peptides which
overlap, or are located close to, B-cell epitopes in the same protein
may determine antibody responses through specific T-cell helper
functions. This is consistent with the experimental finding that a
single amino acid change in HA1 of H3N2 can abrogate both
antibody binding and CD4+ response and that there was frequent
coincidence of B and T-cell epitopes on HA [23,48]. Overlap of
CD8+ epitopes with B-cell epitopes has also been documented in
other influenza A viruses [49]. In the case of vaccinia, Sette et al have
demonstrated a deterministic linkage between a CD4+ epitope
providing specific help to B-cells binding an epitope located in the
same protein [50]. Our own in silico analyses of many organisms
show the close association of B-cell epitopes and predicted high
affinity MHC binding sites in coincident epitope groups [34].
The possible pathways of immune pressure and escape of a
mutating virus are summarized in Figure 13. A mutated virus has
an altered binding interface with an existing antibody (see red
pathway in Figure 13) but through changed T-cell helper functions
(blue pathway), it may also recall a different spectrum of B-
memory, and simultaneously stimulate a different de novo spectrum
of B-cells from those of its un-mutated predecessor. While escape
from pre-existing antibody is essentially the direct random effect of
mutation, the response mediated by CD4+T helper cells is defined
by host HLA and, as we show, may vary between hosts of different
HLA. Mutation also has the capability to change CD8+ mediated
immune pressure (green pathway), although this may be more
important for other influenza proteins.
We should be cautious in extrapolating based on analysis of one
protein. However, the hemagglutinin protein presents a special
case as the primary site of binding of neutralizing antibody and cell
entry receptors. The essential role of B-cells together with CD4+
cells in enabling a T-dependent antibody response and recovery
from influenza infection has been shown [16,51–53]. Influenza
does not infect normal B-cells [32], which implies that their role as
APC differs from that of dendritic cells and macrophages which
are exposed to the full gamut of viral proteins during infection or
phagocytosis [29]. Recognition by B-cell receptors of hemagglu-
tinin, followed by internalization, leads to exposure to and/or
uptake of coincident MHC binding peptides allowing immediate
MHC binding, presentation to T-cells, and recruitment of T-
helper cells [54]. Following re-infection with a virus where one or
more amino acid changes have occurred in a cognate T-cell
Figure 11. Position of peptides in which high affinity MHC-II binding is lost in cluster transition. Axes and lanes as described in Figure 10.
The color scale shown in the scale at left is the count of amino acid changes at a given position for all HLAs which result in the category of change
mapped.
doi:10.1371/journal.pone.0026711.g011
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the balance of T-helper clones (see Figure 13 inset). This may
favor selected clonotypes among the original polyclone of B-
memory cells, and lead to either escape or heterosubtypic
immunity. This suggests that host immunogenetics play a more
active and possibly determinant role in antigenic drift of influenza
viruses. In a recent analogous study, Tong et al have described the
role of MHC-I driven evolution of Chikungunya virus [55].
The focus on MHC binding brings to the fore consideration of
the diversity of HLA. Figures 5 and 6 show that each HLA has a
different response to the peptides in any specific virus isolate,
indicating that the outcome of infection is unique to the virus-host
combination. Figures 10,11,12 show how over 34 years the pattern
of change in MHC binding across all alleles is generally in the same
regions of the protein, but that the detail for each HLA allele is
different. A single amino acid change may cause a gain of binding
sites for some HLAs but loss for others. Most hosts are heterozygous
at each locus of the HLA and each allele will have a compensating
effect. Likewise within a mixed population different pressures arise
from each successive heterozygous host causing a different selection
pressure. Indeed the outcome of infection may depend not only on
the conjunction of the strain of virus with the HLA alleles of the
current host, but on the selective pressure applied by the prior host’s
immunogenetics. We can also envision that a less genetically diverse
population may elicit a more directional selection. There are
examples of this for other viruses [56].
While several models of the evolution of H3N2 have been
proposed [9,11,57–60], they rely on analysis of virus genotype
and antigenicity as determined only by antibody binding. These
previous approaches allow modeling of many features of strain
emergence. However, they do not take full account of how
changes in host genotype also exert selective pressure. This has
been examined experimentally for single HLA peptide interac-
tions [27]. A number of studies have identified key amino acid
changes in HA1 associated with antibody escape [9,11,14];
however each amino acid change potentially impacts the
binding of MHC-II molecules in 15 registers, each with the
potential to affect T-cell helper f u n c t i o n( F i g u r e3 ) .H e n c eo u r
findings reflect a more complex picture in which potential
T-cell epitopes come and go with amino acid changes, and do
so in a pattern that is unique to each HLA allele. This pattern
is not readily appreciated by experimental single epitope
characterization.
The hierarchies of MHC binding patterns (Figure 6) show that
some HLA have a consistently lower absolute binding affinity to
HA1 than others and some are more variable than others.
Whether this translates to changes in CD4+ response or clinical
outcome is not known. A number of field observations have linked
severity of influenza or vaccine response to HLA [61–64] but
given the number of variables and the small size of some of these
studies, no definitive conclusions could be drawn. Patients with
DRB1*09:01 have been reported to respond less well to
Figure 12. Position of peptides in which high affinity MHC-II binding is conserved in cluster transition. Axes and lanes as described in
Figure 10. The color scale shown in the scale at left is the count of amino acid changes at a given position for all HLAs which result in the category of
change mapped.
doi:10.1371/journal.pone.0026711.g012
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[66]. We show DRB3*01:01 and DRB1*13:02 to be consistently
lower affinity binders than other HLAs.
We are not aware of any specific studies in which HLA is linked
to duration of influenza viral shedding although the diversity of
HLA-determined T-cell response suggests variation is likely.
Immunocompromised hosts have been observed to shed influenza
A virus longer [67–69]. As a further step, experimental studies in
horses [70] and birds [71] have shown that longer shedding is
associated with the emergence of more new variant viruses. A
small extension of shedding on an individual basis could have a
significant compound effect in a population on the eventual
number of new variants generated over time. This points to the
possibility of immunogenetically based ‘‘incubator’’ individuals or
populations which have a greater propensity to seed new virus
variants for spread into global circulation. Other infections or
diseases which affect B-cell numbers, function or susceptibility to
infection could also be expected to change the selective process
invoked by T-helper responses [32,72].
Understanding the causes and extent of immunogenetically
driven variation in the response to influenza is important to the
development of broadly effective vaccines [65]. Vaccinal epitopes
should be selected to protect all immunogenetic groups and to
provide heterosubtypic immunity. Also, if influenza vaccines
focused primarily on eliciting a T-cell response are to be
developed, whether from HA or other proteins, a prerequisite
will be to have a clearer understanding of how much variation in
T-cell response occurs among individuals. The methods described
here offer a way to examine such variability. Efforts to generate a
universal vaccine for influenza should take into consideration the
possibility that a T-cell epitope closely associated with a
neutralizing B-cell epitope may be needed to ensure memory.
This study presents predicted MHC binding data for only one of
the proteins of influenza A virus; it clearly provokes broader large
scale analysis of the complete array of influenza proteins and other
important serogroups of the virus, as well as application as a cost
effective screening method which can help focus additional
experimental studies.
Acronyms Used
ic50: inhibitory concentration 50.
AROC: Area under the receiver operator characteristic curve
s: one standard deviation.
Supporting Information
Figure S1 Relationship between MHC binding predic-
tions and curated epitope categorizations including
redundant epitopes.
(PDF)
Figure S2 Relationship between B-cell epitope sequence
predictions and curated epitope categorizations.
(PDF)
Figure S3 Cluster dendrogram of predicted binding
patterns of peptides in 447 HA1 to A*02:01.
(PDF)
Figure S4 Cluster dendrogram of predicted binding
patterns of peptides in 447 HA1 to DRB1*04:01.
(PDF)
Figure 13. Summary of pathways for antigenic escape from immunologic pressure. The flow diagram summarizes the consequences of
virus mutation. The inset panel is a hypothetical example of the change in the polyclonal spectrum of antibody and T-helper cells as a result of
mutation. A mutation in the viral protein at the position marked by the asterisk and dotted line causes loss of MHC binding at that position and
hence no further stimulation of T helper clone TH-D and hence loss of antibody of the clonotype B–D.
doi:10.1371/journal.pone.0026711.g013
Patterns of Predicted Epitopes in Influenza H3N2
PLoS ONE | www.plosone.org 15 October 2011 | Volume 6 | Issue 10 | e26711Figure S5 Hierarchical cluster of predicted MHC-I and
MHC-II binding to HA1 from 10 cluster representative
isolates.
(PDF)
Figure S6 Predicted high affinity MHC-II binding
peptides gained, lost and conserved in HA1 in transi-
tions between temporal clusters of H3N2.
(PDF)
Figure S7 Position of peptides in which change in MHC-
II binding occurs in cluster transition.
(PDF)
Table S1 Epitope set from IEDB used for validation.
(PDF)
Table S2 Example of data set showing change in
predicted MHC binding affinity with cluster transition
changes in amino acids.
(PDF)
Acknowledgments
The authors thank Drs. Gary Splitter and Michael Imboden for their
thoughtful comments.
Author Contributions
Conceived and designed the experiments: EJH RDB. Performed the
experiments: EJH RDB. Analyzed the data: EJH RDB. Wrote the paper:
EJH RDB.
References
1. Suzuki Y, Ito T, Suzuki T, Holland RE, Jr., Chambers TM, et al. (2000) Sialic
acid species as a determinant of the host range of influenza A viruses. J Virol 74:
11825–11831.
2. Horimoto T, Kawaoka Y (1994) Reverse genetics provides direct evidence for a
correlation of hemagglutinin cleavability and virulence of an avian influenza A
virus. J Virol 68: 3120–3128.
3. Tewari MK, Sinnathamby G, Rajagopal D, Eisenlohr LC (2005) A cytosolic
pathway for MHC class II-restricted antigen processing that is proteasome and
TAP dependent. Nat Immunol 6: 287–294. ni1171 [pii];10.1038/ni1171 [doi].
4. Tscherne DM, Garcia-Sastre A (2011) Virulence determinants of pandemic
influenza viruses. J Clin Invest 121: 6–13. 44947 [pii];10.1172/JCI44947 [doi].
5. Gerhard W (2001) The role of the antibody response in influenza virus infection.
Curr Top Microbiol Immunol 260: 171–190.
6. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-
binding sites of Hong Kong influenza haemagglutinin and their involvement in
antigenic variation. Nature 289: 373–378.
7. Ferguson NM, Anderson RM (2002) Predicting evolutionary change in the
influenza A virus. Nat Med 8: 562–563. 10.1038/nm0602-562 [doi];nm0602-
562 [pii].
8. Smith DJ (2003) Applications of bioinformatics and computational biology to
influenza surveillance and vaccine strain selection. Vaccine 21: 1758–1761.
S0264410X03000689 [pii].
9. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al.
(2004) Mapping the antigenic and genetic evolution of influenza virus. Science
305: 371–376. 10.1126/science.1097211 [doi];1097211 [pii].
10. Plotkin JB, Dushoff J, Levin SA (2002) Hemagglutinin sequence clusters and the
antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A 99:
6263–6268. 10.1073/pnas.082110799 [doi];082110799 [pii].
11. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM (1999) Predicting the
evolution of human influenza A. Science 286: 1921–1925. 7945 [pii].
12. Lee MS, Chen JS (2004) Predicting antigenic variants of influenza A/H3N2
viruses. Emerg Infect Dis 10: 1385–1390.
13. ChiXS,BolarTV,ZhaoP,TamJS,RappaportR,etal.(2005)Molecularevolution
of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003. J Clin
Microbiol 43: 6130–6132. 43/12/6130 [pii];10.1128/JCM.43.12.6130-6132.
2005 [doi].
14. Both GW, Sleigh MJ, Cox NJ, Kendal AP (1983) Antigenic drift in influenza
virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and
sequential amino acid changes at key antigenic sites. J Virol 48: 52–60.
15. Scherle PA, Palladino G, Gerhard W (1992) Mice can recover from pulmonary
influenza virus infection in the absence of class I-restricted cytotoxic T cells.
J Immunol 148: 212–217.
16. Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K (1997) Role
of the B-cell response in recovery of mice from primary influenza virus infection.
Immunol Rev 159: 95–103.
17. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC (2006) Cell-mediated
protection in influenza infection. Emerg Infect Dis 12: 48–54.
18. McMichael AJ, Michie CA, Gotch FM, Smith GL, Moss B (1986) Recognition
of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen
Virol 67(Pt 4): 719–726.
19. Mozdzanowska K, Furchner M, Maiese K, Gerhard W (1997) CD4+ T cells are
ineffective in clearing a pulmonary infection with influenza type A virus in the
absence of B cells. Virology 239: 217–225.
20. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC (2002) Compromised
influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice.
J Virol 76: 12388–12393.
21. Babon JA, Cruz J, Orphin L, Pazoles P, Co MD, et al. (2009) Genome-wide
screening of human T-cell epitopes in influenza A virus reveals a broad spectrum
of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuramin-
idases. Hum Immunol 70: 711–721. S0198-8859(09)00144-X [pii];10.1016/
j.humimm.2009.06.004 [doi].
22. Richards KA, Chaves FA, Krafcik FR, Topham DJ, Lazarski CA, et al. (2007)
Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally
broad pattern of immunodominance in the primary HLA-DR1-restricted CD4
T-cell response to influenza virus hemagglutinin. J Virol 81: 7608–7619.
JVI.02834-06 [pii];10.1128/JVI.02834-06 [doi].
23. Barnett BC, Graham CM, Burt DS, Skehel JJ, Thomas DB (1989) The immune
response of BALB/c mice to influenza hemagglutinin: commonality of the B cell
and T cell repertoires and their relevance to antigenic drift. Eur J Immunol 19:
515–521. 10.1002/eji.1830190316 [doi].
24. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A (2000) Human memory
CTL response specific for influenza A virus is broad and multispecific. Hum
Immunol 61: 438–452. S0198-8859(00)00105-1 [pii].
25. Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, et al.
(2000) Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape
from recognition by cytotoxic T lymphocytes. J Virol 74: 6800–6807.
26. Boon AC, de MG, Graus YM, Fouchier RA, Sintnicolaas K, et al. (2002)
Sequence variation in a newly identified HLA-B35-restricted epitope in the
influenza A virus nucleoprotein associated with escape from cytotoxic T
lymphocytes. J Virol 76: 2567–2572.
27. Berkhoff EG, Geelhoed-Mieras MM, Jonges M, Smith DJ, Fouchier RA, et al.
(2007) An amino acid substitution in the influenza A virus hemagglutinin
associated with escape from recognition by human virus-specific CD4+ T-cells.
Virus Res 126: 282–287. S0168-1702(07)00058-5 [pii];10.1016/j.virusres.2007.
02.018 [doi].
28. Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, et al.
(2004) A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the
human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.
J Virol 78: 5216–5222.
29. VanoOsten AR, McGill J, Legge KL (2010) Quantification of the frequency and
multiplicity of infection of respiratory- and lymph node-resident dendritic cells
during influenza virus infection. PLoS One 5: e12902. 10.1371/journal.
pone.0012902 [doi].
30. Hamilton-Easton A, Eichelberger M (1995) Virus-specific antigen presentation
by different subsets of cells from lung and mediastinal lymph node tissues of
influenza virus-infected mice. J Virol 69: 6359–6366.
31. Crowe SR, Turner SJ, Miller SC, Roberts AD, Rappolo RA, et al. (2003)
Differential antigen presentation regulates the changing patterns of CD8+ T cell
immunodominance in primary and secondary influenza virus infections. J Exp
Med 198: 399–410. 10.1084/jem.20022151 [doi];jem.20022151 [pii].
32. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, et al. (2004)
Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen
Virol 85: 2347–2356. 10.1099/vir.0.79958-0 [doi];85/8/2347 [pii].
33. Bremel RD, Homan EJ (2010) An integrated approach to epitope analysis I:
Dimensional reduction, visualization and prediction of MHC binding using
amino acid principal components and regression approaches. Immunome Res 6:
7. 1745-7580-6-7 [pii];10.1186/1745-7580-6-7 [doi].
34. Bremel RD, Homan EJ (2010) An integrated approach to epitope analysis II: A
system for proteomic-scale prediction of immunological characteristics. Im-
munome Res 6: 8. 1745-7580-6-8 [pii];10.1186/1745-7580-6-8 [doi].
35. Lund O, Nielsen M, Lundegaard C, Kesmir C, Brunak S (2005) Immunological
Bioinformatics. CambridgeMA: MIT Press.
36. SAS Institute Inc (2010) JMPH 9 Modelling and Multivariate Methods. Cary,
NC: SAS Institute Inc.
37. Wold S, Sjorstrom M, Eriksson L (2001) PLS-regression: a basic tool of
chemometrics. Chemometrics and Intelligent Laboratory Systems 58: 109–130.
38. Greenbaum J, Sidney J, Chung J, Brander C, Peters B, et al. (2011) Functional
classification of class II human leukocyte antigen (HLA) molecules reveals seven
different supertypes and a surprising degree of repertoire sharing across
supertypes. Immunogenetics;10.1007/s00251-011-0513-0 [doi].
39. Pham DT, Dimov S, Nguyen CD (2005) Selection of K in K-means clustering.
J Mech Eng Sci 219: 103–119.
Patterns of Predicted Epitopes in Influenza H3N2
PLoS ONE | www.plosone.org 16 October 2011 | Volume 6 | Issue 10 | e2671140. Savitzky A, Golay MJE (1964) Smoothing and differentiation of data by
simplified least squares procedures. Anal Chem 36: 1627–1639.
41. Desmet J, Meersseman G, Boutonnet N, Pletinckx J, De CK, et al. (2005)
Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring
method and experimental validation. Proteins 58: 53–69. 10.1002/prot.20302
[doi].
42. Johnson NL (1949) Systems of frequency curves generated by methods of
translation. Biometrika 36: 149–176.
43. Baumgartner CK, Ferrante A, Nagaoka M, Gorski J, Malherbe LP (2010)
Peptide-MHC class II complex stability governs CD4 T cell clonal selection.
J Immunol 184: 573–581. jimmunol.0902107 [pii];10.4049/jimmunol.0902107
[doi].
44. Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, et al. (2005) The
kinetic stability of MHC class II:peptide complexes is a key parameter that
dictates immunodominance. Immunity 23: 29–40. S1074-7613(05)00202-5
[pii];10.1016/j.immuni.2005.05.009 [doi].
45. Constant SL, Bottomly K (1997) Induction of Th1 and Th2 CD4+ T cell
responses: the alternative approaches. Annu Rev Immunol 15: 297–322.
10.1146/annurev.immunol.15.1.297 [doi].
46. Roti M, Yang J, Berger D, Huston L, James EA, et al. (2008) Healthy human
subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol
180: 1758–1768. 180/3/1758 [pii].
47. Crowe SR, Miller SC, Brown DM, Adams PS, Dutton RW, et al. (2006) Uneven
distribution of MHC class II epitopes within the influenza virus. Vaccine 24:
457–467. S0264-410X(05)00779-6 [pii];10.1016/j.vaccine.2005.07.096 [doi].
48. Barnett BC, Hartlmayr I, Graham CM, Thomas DB (1990) Single amino acid
residues in a synthetic peptide of influenza haemagglutinin, HA 1 177–199,
distinguish I-Ad- and I-Ed-restricted T-cell epitopes. Immunology 70: 48–54.
49. Hioe CE, Dybdahl-Sissoko N, Philpott M, Hinshaw VS (1990) Overlapping
cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5
hemagglutinin. J Virol 64: 6246–6251.
50. Sette A, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, et al.
(2008) Selective CD4+ T cell help for antibody responses to a large viral
pathogen: deterministic linkage of specificities. Immunity 28: 847–858. S1074-
7613(08)00235-5 [pii];10.1016/j.immuni.2008.04.018 [doi].
51. Topham DJ, Doherty PC (1998) Clearance of an influenza A virus by CD4+ T
cells is inefficient in the absence of B cells. J Virol 72: 882–885.
52. Mozdzanowska K, Furchner M, Zharikova D, Feng J, Gerhard W (2005) Roles
of CD4+ T-cell-independent and -dependent antibody responses in the control
of influenza virus infection: evidence for noncognate CD4+ T-cell activities that
enhance the therapeutic activity of antiviral antibodies. J Virol 79: 5943–5951.
53. Mozdzanowska K, Furchner M, Maiese K, Gerhard W (1997) CD4+ T cells are
ineffective in clearing a pulmonary infection with influenza type A virus in the
absence of B cells. Virology 239: 217–225. S0042-6822(97)98882-6 [pii];10.1006/
viro.1997.8882 [doi].
54. Batista FD, Iber D, Neuberger MS (2001) B cells acquire antigen from target
cells after synapse formation. Nature 411: 489–494. 10.1038/35078099
[doi];35078099 [pii].
55. Tong JC, Simarmata D, Lin RT, Renia L, Ng LF (2010) HLA class I restriction
as a possible driving force for Chikungunya evolution. PLoS One 5: e9291.
10.1371/journal.pone.0009291 [doi].
56. de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, et al.
(1993) HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+
population. Science 260: 98–100.
57. Bedford T, Cobey S, Beerli P, Pascual M (2010) Global migration dynamics
underlie evolution and persistence of human influenza A (H3N2). PLoS Pathog
6: e1000918. 10.1371/journal.ppat.1000918 [doi].
58. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, et al. (2008) The global
circulation of seasonal influenza A (H3N2) viruses. Science 320: 340–346. 320/
5874/340 [pii];10.1126/science.1154137 [doi].
59. Koelle K, Cobey S, Grenfell B, Pascual M (2006) Epochal evolution shapes the
phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314:
1898–1903. 314/5807/1898 [pii];10.1126/science.1132745 [doi].
60. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008)
The genomic and epidemiological dynamics of human influenza A virus. Nature
453: 615–619. nature06945 [pii];10.1038/nature06945 [doi].
61. Lebiush M, Rannon L, Kark JD (1981) The relationship between epidemic
influenza (A(H1N1) and ABO blood group. J Hyg (Lond) 87: 139–146.
62. Maruyama N, Yoshida Y, Inamatsu T, Fujita K, Handa S, et al. (2004) HLA-
DR allotype is associated with responsiveness to influenza vaccine in elderly
Japanese. Geriat Gerentol Int 4: 234–237.
63. Gelder CM, Lambkin R, Hart KW, Fleming D, Williams OM, et al. (2002)
Associations between human leukocyte antigens and nonresponsiveness to
influenza vaccine. J Infect Dis 185: 114–117. JID010636 [pii];10.1086/338014
[doi].
64. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008)
Evidence for a heritable predisposition to death due to influenza. J Infect Dis
197: 18–24. 10.1086/524064 [doi].
65. Poland GA, Ovsyannikova IG, Jacobson RM (2008) Immunogenetics of
seasonal influenza vaccine response. Vaccine 26 Suppl 4: D35–D40.
66. Ruben FL, Fireman P, LaPorte RE, Drash AL, Uhrin M, et al. (1988) Immune
responses to killed influenza vaccine in patients with type 1 diabetes: altered
responses associated with HLA-DR 3 and DR 4. J Lab Clin Med 112: 595–602.
67. Giannella M, Alonso M, Garcia dV, Roa PL, Catalan P, et al. (2010) Prolonged
viral shedding in pandemic influenza A(H1N1): clinical significance and viral load
analysis in hospitalized patients. Clin Microbiol Infect. 10.1111/j.1469-0691.
2010.03399.x [doi].
68. Pinsky BA, Mix S, Rowe J, Ikemoto S, Baron EJ (2010) Long-term shedding of
influenza A virus in stool of immunocompromised child. Emerg Infect Dis 16:
1165–1167.
69. Li CC, Wang L, Eng HL, You HL, Chang LS, et al. (2010) Correlation of
pandemic (H1N1) 2009 viral load with disease severity and prolonged viral
shedding in children. Emerg Infect Dis 16: 1265–1272.
70. Murcia PR, Baillie GJ, Daly J, Elton D, Jervis C, et al. (2010) Intra- and
interhost evolutionary dynamics of equine influenza virus. J Virol 84:
6943–6954. JVI.00112-10 [pii];10.1128/JVI.00112-10 [doi].
71. Iqbal M, Xiao H, Baillie G, Warry A, Essen SC, et al. (2009) Within-host
variation of avian influenza viruses. Philos Trans R Soc Lond B Biol Sci 364:
2739–2747. 364/1530/2739 [pii];10.1098/rstb.2009.0088 [doi].
72. Cagigi A, Nilsson A, Pensieroso S, Chiodi F (2010) Dysfunctional B-cell
responses during HIV-1 infection: implication for influenza vaccination and
highly active antiretroviral therapy. Lancet Infect Dis 10: 499–503. S1473-
3099(10)70117-1 [pii];10.1016/S1473-3099(10)70117-1 [doi].
Patterns of Predicted Epitopes in Influenza H3N2
PLoS ONE | www.plosone.org 17 October 2011 | Volume 6 | Issue 10 | e26711